-
×
N-Desmethyl-BDPC
1 × $28.00
New
SR-14968
$28.00
SR-14968 is an opioid drug, an active agonist at the μ-opioid receptors, a derivative of brorphine and SR-17018 and has similar effects on the body.This drug is under research as an analgesic agent with a lower risk of overdose, opioid dependence and other side effects.
You can buy SR-14968 online at a price:
| QUANTITY | Disc (%) | Price per gram |
| 1 g | – | – |
| 2 g | 0 % | $28.00 |
| 5 g | 14 % | $24.00 |
| 10 g | 25% | $21.00 |
| 25 g | 44% | $15.50 |
| 50 g | 57 % | $12.00 |
| 100 g | 72% | $8.00 |
| 250 g | 73% | $7.40 |
| 500 g | 75% | $7.00 |
| 1000 g | 76% | $6.50 |
SR-14968 is an opioid drug, an active agonist at the μ-opioid receptors, a derivative of brorphine and SR-17018 and has similar effects on the body.This drug is under research as an analgesic agent with a lower risk of overdose, opioid dependence and other side effects.
Chemistry
SR-14968 is closely related to drugs such as brorphine and SR-17018.
Pharmacology
SR-14968 is a designer drug and the toxicological and pharmacological properties are not fully understood.
Studies in mice have shown that SR-14968 exhibits agonistic activity in vitro as a typical opioid agonist at higher doses, but is less safe than fentanyl. This drug is an excellent analgesic and can have a relaxing effect.
Legal status
Unclear legal status
Technical Information:
Product Name: SR-14968
Other Name(s): US10751335, Example 2
IUPAC Name: 3-[1-[1-(4-bromophenyl)ethyl]piperidin-4-yl]-5,6-dichloro-1H-benzimidazol-2-one
CAS: 2133455-40-8
Molar Mass: 469.2 g/mol
Molecular Formula: C20H20BrCl2N3O
InChi Code: InChI=1S/C20H20BrCl2N3O/c1-12(13-2-4-14(21)5-3-13)25-8-6-15(7-9-25)26-19-11-17(23)16(22)10-18(19)24-20(26)27/h2-5,10-12,15H,6-9H2,1H3,(H,24,27)
InChIKey: DJSSLECNUQMYKG-UHFFFAOYSA-N
Canonical SMILES: CC(C1=CC=C(C=C1)Br)N2CCC(CC2)N3C4=CC(=C(C=C4NC3=O)Cl)Cl
Formulation: A solid
Create a preliminary purchase request. Check stock availability. Communication with support:
Related products
Sale!
New
New
Sale!
New
New
New
New
New
New
